Molecular profile of apomucin and p53 protein as predictors of malignancy in intraductal papillary mucinous neoplasms of the pancreas

Hepato-Gastroenterology

Volumn 58, Issue 110-111, 2011, Pages 1791-1795

  Mizumoto, Masaki ^a   Honjo, Gen ^a   Kobashi, Yoichiro ^a   Awane, Masaaki ^a   Matsusue, Satoru ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

Invasion; IPMNs; Ki67; Mucin antigen; p53

Indexed keywords

KI 67 ANTIGEN; MUCIN 1; MUCIN 2; MUCIN 5AC; PROTEIN P53;

ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; DYSPLASIA; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; FEMALE; GASTRIC MUCINS; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MUCIN-1; MUCIN-2; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 83355167009     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sohn TA, Yeo CJ, Cameron JL, et al.: Intarductal papillary mucinous neoplasm of the pancreas. Ann Surg 2004; 239:788-799. (Pubitemid 38669430)
2. Suzuki Y, Atomi Y, Sugiyama M, et al.: Cystic neoplasm of the pancreas: a Japanese multi-institutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004; 28:241-246. (Pubitemid 38437316)
3. Mizumoto M, Honjyo G, Kobashi Y, et al.: Preoperative evaluation of malignancy in intraductal papillary mucinous neoplasms fo the pancreas, especially in relation to dysplastic epithelial change. Hepato-gastroentelorogy 2008; 55:704-707. (Pubitemid 351741532)
4. Longnecker DS, Adsey NV, Castillo CF, et al.: Histopathological diagnosis of pancretatic intraepithelial neoplasma and intraductal papillary-mucinous neoplasms: Interobserver agreetment. Pancreas 2005; 31:344-349. (Pubitemid 41566883)
5. Hruban RH, Takaori K, Klimsta DS, et al.: An illustrated concensus on the classification of pancreatic intraepithelial neoplasma and intraductal papillary mucinous neoplasms. Pancreas 2005; 31:977-987.
6. Yonezawa S, Sato E: Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathology International 1997; 47:813-830. (Pubitemid 28087380)
7. Lee MJ, Lee HS, Kim WH, et al.: Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003; 16:403-410. (Pubitemid 36618459)
8. Lau SK, Weiss LM, Chu PG: Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol 2004; 122:61-69. (Pubitemid 38849873)
9. Lee HS, Lee HK, Kim HS, et al.: MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 2001; 92:1427-1434. (Pubitemid 32947826)
10. Sessa F, Capella C, Bonato M, et al.: Intraductal papillary-mucinouse tumors represent a distinct group of pancreatic neoplasm: an investigation of tumor cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425:357-367.
11. Jeong S, Lee DH, Lee JI, et al.: Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma. World J Gastroenterol 2005; 11:6765-6769. (Pubitemid 43092445)
12. Terada T, Ohta T, Kitamura Y, Ashida K, et al.: Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study. Arch Pathol Lab Med 1998; 122(1):42-46. (Pubitemid 28212605)
13. Longnecker DS, Adler G, Hruban RH, et al.: World Health Organization Classification of Tumors. IARC Press, Lyon 2000: 237-240.
14. Japan Pancreas Society: Classification of pancreatic carcinoma, 2nd Engl. Ed. Kanehara & Co. Ltd, Tokyo 2003.
15. Balague C, Gambus G, Carrato C, et al.: Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology 1994; 106:1054-1061.
16. Adsay NV, Merati K, Andea A, et al.: The dichtomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: Differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002; 15:1087-1095.
17. Li Y, Ren J, Yu W, et al.: The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. Biol Chem 2001; 276:35239-35242.
18. Yonezawa S, Taira M, Osako M, Kubo M, et al.: MUC1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int 1998; 48:319-322. (Pubitemid 28328315)
19. Yonezawa S, Sueyoshi K, Nomoto M, et al.: MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol 1997; 28:344-352. (Pubitemid 27106088)
20. Terris B, Dubois S, Buisine MP, et al.: Mucin gene expression in intraductal papillary-mucinous pancreatic tumors and related lesions. J Pathol 2002; 197:632-637.
21. Nakamura A, Horinouchi M, Goto M, et al.: New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignamcy. J Pathol 2002; 197:201-210. (Pubitemid 34567608)
22. Velcich A, Yang W, Heyer J, et al.: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002; 295:1726-9. (Pubitemid 34202910)
23. Ueda M, Miura Y, Kunihiro O, et al.: MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Hepatogastroenterology 2005; 52:398-403. (Pubitemid 40469434)
24. Furukawa T, Kloppel G, Volkan Adsay N, et al.: Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005; 447:794-799. (Pubitemid 41728866)
25. Kohlgraf KG, Gawron AJ, Higashi M, et al.: Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Res 2003; 63:5011-5020. (Pubitemid 37022639)
26. Wei X, Xu H, Kufe D: Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res 2007; 67:1853-1858. (Pubitemid 46383412)